ALAS1 Antikörper (AA 480-530)
Kurzübersicht für ALAS1 Antikörper (AA 480-530) (ABIN2470088)
Target
Alle ALAS1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 480-530
-
Aufreinigung
- Protein G Column
-
Immunogen
- ALAS1 antibody was raised against amino acids 480 - 530 of ALAS1 (Human).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- ALAS1 antibody can be used in ELISA, and immunohistochemistry starting at 5 μg/mL.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, 0.2 % gelatin, 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store ALAS1 antibody at 4 °C for short term applications. For long term storage, aliquot and -20 °C.
-
-
- ALAS1 (Aminolevulinate, delta-, Synthase 1 (ALAS1))
-
Andere Bezeichnung
- ALAS1
-
Hintergrund
- ALAS-1 (EC 2.3.1.37) is a nuclear-encoded mitochondrial matrix enzymecatalyzing the condensation of glycine with succinyl-CoA to form delta-amino levulinate, CO2 and CoA. It regulates the first and rate-limiting step of heme biosynthetic pathway. It is one of the two isoforms of ALAS and is a pyridoxal-5 phosphate dependant housekeeping enzyme. It is ubiquitously expressed and is responsible of providing heme for cytochromes and other hemoproteins. ALAS1 in liver undergoes negative feedback regulation by heme. Transcription of ALAS1 gene is stimulated by cAMP and respiratory uncoupling whereas Phorbol esters and insulin repress ALAS1 gene expression. ALAS1 is suggested to be involved in reciprocal regulation of Heme biosynthesis and circadian clock suggesting a potential target for treatment of circadian disorders. ALAS1 gene expression is down regulated in Acute Liver failure resulting in altered heme metabolism and liver function.
-
Gen-ID
- 211
-
UniProt
- P13196
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-